Common Stock SEC Reporting - Current
OTC Pink Current Information
Contact Info
  • 88 Prospect Street
  • Suite 210
  • La Jolla, CA 92037

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report May 31, 2017 10-Q
CIK 0001621221
Fiscal Year End 8/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 7389 - Business services, misc
Incorporated In: NV, USA
Year of Inc. 2011
Employees Not Available
Company Officers/Contacts
Gregory Gorgas President, CEO, CFO
Peter O'Brien Senior VP
Company Directors
Connie Matsui Chairwoman
Dr. Douglas W. Blayney
Gregory Gorgas
Steven Kelly
Company Notes
  • Formerly=Reactive Medical Inc. until 5-2017
  • Formerly=Knight Knox Development Corp. until 2-2017
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States

Legal Counsel
Satterlee Stephens Burke & Burke LLP
230 Park Avenue
11th Floor
New York, NY, 10169
United States

Investor Relations Firm
Not Available
ARTL Security Details
Share Structure
Market Value1 Not Available
Authorized Shares 75,000,000 a/o Jul 15, 2015
Outstanding Shares 9,800,000 a/o Apr 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s)
Globex Transfer, LLC
Shareholders of Record 30 a/o Dec 11, 2015
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security